Found: 14
Select item for more details and to access through your institution.
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e148, doi. 10.1111/bjh.17365
- By:
- Publication type:
- Article
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 494, doi. 10.1111/bjh.16853
- By:
- Publication type:
- Article
Are formalin‐fixed and paraffin‐embedded tissues fit for proteomic analysis?
- Published in:
- Journal of Mass Spectrometry, 2020, v. 55, n. 8, p. 1, doi. 10.1002/jms.4347
- By:
- Publication type:
- Article
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2543, doi. 10.1007/s00277-023-05353-9
- By:
- Publication type:
- Article
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 755, doi. 10.1007/s00277-023-05111-x
- By:
- Publication type:
- Article
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 63, doi. 10.1007/s00277-022-05025-0
- By:
- Publication type:
- Article
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 7, p. 1871, doi. 10.1007/s00277-020-04382-y
- By:
- Publication type:
- Article
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.
- Published in:
- 2015
- By:
- Publication type:
- Letter
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1488, doi. 10.3390/cancers12061488
- By:
- Publication type:
- Article
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164499
- By:
- Publication type:
- Article
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 5, p. 517, doi. 10.1007/s13402-018-0389-1
- By:
- Publication type:
- Article
AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2018, v. 41, n. 4, p. 455, doi. 10.1007/s13402-018-0382-8
- By:
- Publication type:
- Article
Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 93, doi. 10.1002/jha2.827
- By:
- Publication type:
- Article
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20717-9
- By:
- Publication type:
- Article